Nucleic acids have been among the first targets for antitumor drugs and antibiotics. With the
unveiling of new biological roles in regulation of gene expression, specific DNA and RNA …

Proteome analysis is now emerging as key technology for deciphering biological processes
and the discovery of biomarkers for diseases from tissues and body fluids. The complexity …

Cordyceps sinensis, a well-known and valued traditional Chinese medicine, is also called
DongChong**aCao (winter worm summer grass) in Chinese. It is commonly used to …

Noninvasive diagnosis of kidney diseases and assessment of the prognosis are still
challenges in clinical nephrology. Definition of biomarkers on the basis of proteome …

Detection and characterization of nano delivery systems is an essential part of
understanding the benefits as well as the potential toxicity of these systems in food. This …

Over the last two decades, coupled capillary electrophoresis (CE)–mass spectrometry (MS)
has developed into a generally accepted technique with a wide applicability. A growing …

An interface for CE‐ESI‐MS that decouples both the electrical and the solution flow rate
requirements of the separation and ionization processes is presented. The interface uses a …

CE‐MS is a successful proteomic platform for the definition of biomarkers in different body
fluids. Besides the biomarker defining experimental parameters, CE migration time and …

Developments in the fields of protein chemistry, proteomics and biotechnology have
increased the demand for suitable analytical techniques for the analysis of intact proteins. In …

The field of clinical proteomics offers opportunities to identify new disease biomarkers in
body fluids, cells and tissues. These biomarkers can be used in clinical applications for …